Market Tracker

12/15 3:00am ET

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

1.49
Delayed Data
As of Dec 14
 -0.01 / -0.67%
Today’s Change
1.20
Today|||52-Week Range
17.04
-71.31%
Year-to-Date
No recent news for Anthera Pharmaceuticals Inc.

Today’s Trading

Previous close1.50
Today’s open1.50
Day’s range1.43 - 1.52
Volume272,941
Average volume (3 months)470,039
Market cap$20.8M
Data as of 4:00pm ET, 12/14/2017

Growth & Valuation

Earnings growth (last year)-62.63%
Earnings growth (this year)--
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)-95.45%
P/E ratioNM
Price/Sales184.93
Price/Book2.24

Competitors

 Today’s
change
Today’s
% change
ABIOARCA Biopharma Inc-0.07-5.17%
KZIAKazia Therapeutics L...-0.17-6.61%
OGENOragenics Inc-0.02-6.68%
CBIOCatalyst Biosciences...+1.02+11.45%
Data as of 4:00pm ET, 12/14/2017

Financials

Next reporting dateMarch 8, 2018
EPS forecast (this quarter)-$0.80
Annual revenue (last year)$145.0K
Annual profit (last year)-$55.5M
Net profit margin-38,291.72%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Craig Thompson
CAO, Senior VP-Finance &
Administration
May Liu
Corporate headquarters
Hayward, California

Forecasts